[1]
N. S. Tamzil, “SIDE EFFECTS OF SECOND-LINE ANTITUBERCULOSIS DRUGS IN MULTI-DRUG RESISTANCE (MDR) TUBERCULOSIS PATIENTS”, JKK, vol. 12, no. 2, pp. 161–169, Apr. 2025.